Micro Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MICRO LABS
MICRO LABS has one hundred and nine approved drugs.
There are ten tentative approvals on MICRO LABS drugs.
Summary for Micro Labs
| US Patents: | 0 |
| Tradenames: | 99 |
| Ingredients: | 99 |
| NDAs: | 109 |
| Patent Litigation for Micro Labs: | See patent lawsuits for Micro Labs |
| PTAB Cases with Micro Labs as petitioner: | See PTAB cases with Micro Labs as petitioner |
Drugs and US Patents for Micro Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Micro Labs | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 091220-004 | Jun 29, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 204777-001 | May 28, 2020 | AT1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 207400-001 | Dec 14, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | TORSEMIDE | torsemide | TABLET;ORAL | 217239-003 | May 1, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | BACLOFEN | baclofen | TABLET;ORAL | 217687-003 | Nov 8, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Micro Labs | TRAVOPROST | travoprost | SOLUTION/DROPS;OPHTHALMIC | 203767-001 | Mar 19, 2021 | AT2 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

